The Magazine for Sleep Professionals
Saturday, August 29, 2026
The role of sleep in optimizing health and well-being is a widely discussed topic in popular culture and research communities. However, one area where discussion is lacking is the interplay between sleep and dermatology. In this article, we discuss the complex interplay between sleep and skin health, as well as […]
React Health and ReactDx, leading companies in respiratory, sleep, and cardiac care, have announced the adoption of new, joint mission and vision statements that underscore their commitment to optimizing individuals’ well-being through pioneering advanced diagnostics and therapeutics. The new mission, “To improve the lives of those we serve by delivering […]
Panthera Dental is pleased to announce a remarkable milestone in its ongoing commitment to innovation and excellence: the company now holds over 110 patents across the dental, medical, and sleep appliance industries. This significant milestone follows their recent amicable settlement with ResMed SAS that resolves all ongoing patent infringement litigation […]
Masimo has announced a groundbreaking update to its advanced health-tracking wearable, the Masimo W1® Sport. The new feature, Sleep Halo™, offers scientifically based sleep analysis, setting a new standard in sleep tracking technology. Unmatched Sleep Data Tracking and Comprehensive Sleep Insights Sleep Halo™ delivers unparalleled overnight sleep data tracking, recording […]
Harmony Biosciences announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for WAKIX® (pitolisant) tablets for the treatment of excessive daytime sleepiness (EDS) in pediatric patients six years of age and older with narcolepsy. The FDA separated the submission into two sNDAs […]
Clinicians today have numerous options for prescribing home sleep apnea testing (HSAT). While sleep laboratory type 1 tests based on polysomnography (PSG) utilize an array of sensors, belts, technologies, and experts to monitor the patient, at-home tests generally gather less information in favor of convenience, comfort, and accessibility. Two respiratory […]
Incannex Healthcare Inc., a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine therapies, is pleased to announce that patient dosing has commenced in the Company’s Phase 2/3 clinical trial to assess the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA). IHL-42X is the Company’s […]
IntelliPAP™ is a new optional tool for physicians to use in noninvasive ventilation for patients with respiratory insufficiency and obstructive sleep apnea (OSA). This innovative device automatically adjusts the positive end-expiratory pressure (PEEP) levels in response to sleep-disordered breathing (SDB) events. To enhance safety, clinicians can set minimum and maximum […]
EnsoData and Parachute Health announced a partnership to expedite care for newly diagnosed sleep disorders like obstructive sleep apnea (OSA) by simplifying the sleep care workflow from diagnostics through therapy prescription ordering. The two organizations will collaborate to create a seamless handoff from a physician-signed sleep report directly through to […]
Poor sleep health affects a significant portion of the American population, with prevalent sleep-related issues impacting overall quality of life.1 A tiered approach to sleep health services is necessary, ranging from intensive interventions for severe cases to more widely accessible options for milder problems. Sleep coaching programs have emerged as […]
